Physician profile
Troy C Gingerich
NPI 1104007319
$18,552.69
in general payments reported to CMS, 2019-2025
14 companies · $2,716 in 2025
The $2,716 reported for 2025 was more than what 83% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,527 · 2020: $1,404 · 2021: $3,514 · 2022: $1,366 · 2023: $2,891 · 2024: $3,134 · 2025: $2,716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,642 · Consulting Fee: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,641.93 |
| Consulting Fee | $1,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $6,657.50 | 2019-2025 | Sprint Pns System |
| Nevro Corp. | $4,389.27 | 2019-2024 | Senza |
| Boston Scientific Corporation | $3,105.61 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Superion Indirect Decompression System |
| Vertiflex, INC. | $1,066.33 | 2019 | |
| Globus Medical, INC. | $920.97 | 2025 | Senza |
| Medtronic, INC. | $833.31 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vectris Surescan |
| Abbott Laboratories | $723.95 | 2019-2025 | Eterna, Proclaim, Octrode |
| Medtronic USA, INC. | $537.76 | 2019-2020 | |
| Vertos Medical, INC. | $85.07 | 2020-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $71.44 | 2024 | Evoke |
| Vertex Pharmaceuticals Incorporated | $57.68 | 2025 | |
| Si-Bone, INC. | $40.74 | 2023 | |
| Relievant Medsystems, INC. | $31.97 | 2020 | |
| Bioventus LLC | $31.09 | 2025 | Xcell |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Gingerich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.